<p>Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at <a href="https://ai-podcast.nvidia.com/">ai-podcast.nvidia.com</a>.</p>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

NVIDIA AI Podcast

AI Chapters

AI Insights

Reviews